The 32nd annual meeting of the European Association for the Study of Diabetes - Macrovascular disease

被引：3

作者：

Bloomgarden, ZT

机构：

来源：

DIABETES CARE | 1997年 / 20卷 / 07期

关键词：

D O I：

10.2337/diacare.20.7.1198

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1198 / 1201

页数：4

共 17 条

[1]

Alderman EL, 1996, NEW ENGL J MED, V335, P217

[2] Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction? [J].

Ball, SG ;

Hall, AS .

AMERICAN HEART JOURNAL, 1996, 132 (01) :244-250

[3] EFFECTS OF EARLY ENALAPRIL TREATMENT ON GLOBAL AND REGIONAL WALL-MOTION IN ACUTE MYOCARDIAL-INFARCTION [J].

CARSTENSEN, S ;

BONARJEE, VVS ;

BERNING, J ;

EDNER, M ;

NILSEN, DWT ;

CAIDAHL, K .

AMERICAN HEART JOURNAL, 1995, 129 (06) :1101-1108

[4] RAMIPRIL - AN UPDATED REVIEW OF ITS THERAPEUTIC USE IN ESSENTIAL-HYPERTENSION AND HEART-FAILURE [J].

FRAMPTON, JE ;

PETERS, DH .

DRUGS, 1995, 49 (03) :440-466

[5]

HANSEN O, 1993, J HYPERTENS, V11, pS55

[6] 10-YEAR MORTALITY-RATE AFTER DEVELOPMENT OF ACUTE MYOCARDIAL-INFARCTION IN RELATION TO CLINICAL HISTORY AND OBSERVATIONS DURING HOSPITAL STAY - EXPERIENCE FROM THE GOTEBORG METOPROLOL TRIAL [J].

HERLITZ, J ;

KARLSON, BW ;

HJALMARSON, A .

CORONARY ARTERY DISEASE, 1993, 4 (12) :1077-1083

[7] Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease [J].

Jonas, M ;

ReicherReiss, H ;

Boyko, V ;

Shotan, A ;

Mandelzweig, L ;

Goldbourt, U ;

Behar, S .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (15) :1273-1277

[8]

KJEKSHUS J K, 1988, Cardiovascular Drugs and Therapy, V2, P113, DOI 10.1007/BF00054261

[9] CLINICAL CHARACTERISTICS AND MORTALITY OF PATIENTS SCREENED FOR ENTRY INTO THE TRANDOLAPRIL CARDIAC EVALUATION (TRACE) STUDY [J].

KOBER, L ;

TORPPEDERSEN, C .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (01) :1-5

[10]

LIU LS, 1995, LANCET, V345, P686

← 1 2 →